BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30686359)

  • 1. [Not Available].
    Pinturaud M; Vasseur M; Odou P
    Bull Cancer; 2018 Dec; 105 Suppl 2():S205-S213. PubMed ID: 30686359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Gauthier J
    Bull Cancer; 2018 Dec; 105 Suppl 2():S214-S217. PubMed ID: 30686360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Rubio MT; Galaine J; Borg C; Daguindau É
    Bull Cancer; 2018 Dec; 105 Suppl 2():S135-S146. PubMed ID: 30686352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Le Bourgeois A
    Bull Cancer; 2018 Dec; 105 Suppl 2():S188-S197. PubMed ID: 30686357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Chabannon C; Larghero J
    Bull Cancer; 2018 Dec; 105 Suppl 2():S198-S204. PubMed ID: 30686358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Rahal I; Cabannes-Hamy A; Boissel N
    Bull Cancer; 2018 Dec; 105 Suppl 2():S158-S167. PubMed ID: 30686354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Salles G; Sesques P; Ferrant E; Safar V; Ghesquieres H; Bachy E
    Bull Cancer; 2018 Dec; 105 Suppl 2():S168-S177. PubMed ID: 30686355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Dourthe MÉ; Yakouben K; Chaillou D; Lesprit E; Dalle JH; Baruchel A
    Bull Cancer; 2018 Dec; 105 Suppl 2():S147-S157. PubMed ID: 30686353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Alcazer V; Delenda C; Poirot L; Depil S
    Bull Cancer; 2018 Dec; 105 Suppl 2():S178-S187. PubMed ID: 30686356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.
    Talarmin C; Kerob S; Cartier F; Madelaine I; Mukenyi S; Schwartz E; Boissel N; Baruchel A; Thieblemont C; Parquet N; Brignier A; Lesprit E; Desproges A; Magdelonnette L; Larghero J; Mebarki M
    Cytotherapy; 2020 Dec; 22(12):792-801. PubMed ID: 32732084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CAR-T cells gene therapy medicines: Regulatory status and pharmaceutical circuits in Europe and France].
    de Jorna R; Madelaine I; Larghero J; Mebarki M
    Bull Cancer; 2021 Oct; 108(10S):S162-S167. PubMed ID: 34920799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital pharmacist's roles and responsibilities with CAR-T medicines.
    Moreno-Martínez ME; Vinent-Genestar J; Muñoz-Sánchez C; Carreras-Soler MJ
    Farm Hosp; 2020 Jan; 44(1):26-31. PubMed ID: 31901059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacist's role in chimeric antigen receptor T cell therapy.
    Booth JP; Kusoski CL; Kennerly-Shah JM
    J Oncol Pharm Pract; 2020 Oct; 26(7):1725-1731. PubMed ID: 32819199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Integration of a hospital pharmacist in the ICU].
    Moch C; Pivot C; Floccard B; Rimmelé T; Paillet C
    Ann Pharm Fr; 2014 Mar; 72(2):90-4. PubMed ID: 24630309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group.
    Nezvalova-Henriksen K; Langebrake C; Bauters T; Moreno-Martinez ME; Ahnfelt E; Ekelund H; Domingos V; Pires V; Bonnin A; Bojanić I; Cabrerizo Y; Terwel S; Tam A
    Bone Marrow Transplant; 2023 Oct; 58(10):1069-1074. PubMed ID: 37528237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse.
    Cummins KD; Gill S
    Leuk Lymphoma; 2018 Jul; 59(7):1539-1553. PubMed ID: 28901790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roles of the hospital pharmacist and the cooperation between hospital pharmacy and insurance pharmacy in the introduction of home parenteral nutrition].
    Kawakami N; Ichiro N
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():182-4. PubMed ID: 15645766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes to supervision in community pharmacy: pharmacist and pharmacy support staff views.
    Bradley F; Schafheutle EI; Willis SC; Noyce PR
    Health Soc Care Community; 2013 Nov; 21(6):644-54. PubMed ID: 23718766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clinical pharmacists in the emergency department of an Australian public hospital: A before and after study.
    Proper JS; Wong A; Plath AE; Grant KA; Just DW; Dulhunty JM
    Emerg Med Australas; 2015 Jun; 27(3):232-8. PubMed ID: 25818918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.